Allegro to start pivotal clinical trials in osteoarthritis patients in 2025 Liege, Belgium – 11 December 2024 (07:30 CET) – Allegro NV, a biomedical company developing transformative ...
Pivotal clinical trial in osteoarthritis patients on track to start in 2025 Liege, Belgium – 4 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing a transformative ...
Stanford engineers have developed an injectable hydrogel depot technology that enables GLP-1 drugs to be administered once every four months, compared to repeated daily injections. Materials engineers ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Blood, as the vital and life-sustaining passageway through the body ...
Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of diabetes and weight control drugs like Ozempic, Mounjaro, ...
French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback